Impact of antiretroviral drugs on the microbiome: unknown answers to important questions.

about

A Lachnospiraceae-dominated bacterial signature in the fecal microbiota of HIV-infected individuals from Colombia, South America.

P2860

Q52355341-67A81AD7-185B-4057-8A34-BF976C764E10

P2860

Impact of antiretroviral drugs on the microbiome: unknown answers to important questions.

Item

http://www.wikidata.org/entity/Q46286824

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Impact of antiretroviral drugs on the microbiome: unknown answers to important questions.

@en

Impact of antiretroviral drugs on the microbiome: unknown answers to important questions.

@nl

type

Item

label

Impact of antiretroviral drugs on the microbiome: unknown answers to important questions.

@en

Impact of antiretroviral drugs on the microbiome: unknown answers to important questions.

@nl

prefLabel

Impact of antiretroviral drugs on the microbiome: unknown answers to important questions.

@en

Impact of antiretroviral drugs on the microbiome: unknown answers to important questions.

@nl

P1476

Impact of antiretroviral drugs on the microbiome: unknown answers to important questions.

@en

P2093

Gustavo Reyes-Terán

http://www.w3.org/2001/XMLSchema#string

Nichole R Klatt

http://www.w3.org/2001/XMLSchema#string

Sandra Pinto-Cardoso

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

P2860

The gut microbiome in human immunodeficiency virus infection

Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection

Current status and prospects of HIV treatment

Noninfectious Diarrhea in HIV Seropositive Individuals: a Review of Prevalence Rates, Etiology, and Management in the Era of Combination Antiretroviral Therapy

HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammation

An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia.

Differential penetration of raltegravir throughout gastrointestinal tissue: implications for eradication and cure.

Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients

Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics.

Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism.

P304

53-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1097/COH.0000000000000428

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2017-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29028667

http://www.w3.org/2001/XMLSchema#string

P921

microbiome

human immunodeficiency virus infectious disease

Retroviridae infectious disease

environment

P932

5718259

http://www.w3.org/2001/XMLSchema#string

Impact of antiretroviral drugs on the microbiome: unknown answers to important questions.

about

P2860

P2860

Impact of antiretroviral drugs on the microbiome: unknown answers to important questions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932